Submission Details
| 510(k) Number | K992712 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 1999 |
| Decision Date | December 06, 1999 |
| Days to Decision | 117 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K992712 is an FDA 510(k) clearance for the SIGMA DIAGNOSTICS ALEXIN LS, MODELS A1219, A1334, a Activated Partial Thromboplastin (Class II — Special Controls, product code GFO), submitted by Sigma Diagnostics, Inc. (St. Louis, US). The FDA issued a Cleared decision on December 6, 1999, 117 days after receiving the submission on August 11, 1999. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7925.
| 510(k) Number | K992712 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 1999 |
| Decision Date | December 06, 1999 |
| Days to Decision | 117 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | GFO — Activated Partial Thromboplastin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7925 |